Observational study of Nab-paclitaxel followed by Anthracycline based regimen as preoperative chemotherapy for ER-negative resectable primary breast cancer - Observational study of Nab-paclitaxel followed by Anthracycline based regimen as preoperative chemotherapy for ER-negative resectable primary breast cancer

SHINKO HOSPITA0 个研究点目标入组 40 人开始时间: 2016年2月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)patients with previous treatment history of nab-paclitaxel 2)active double cancer (synchronous double cancer and metachronous double cancer disease-free period is within 5 years) 3)serious complications (congestiveheart failure, coronary insufficiency, heart disease such as a myocardial infarction and angina pectoris and Arrhythmia requiring treatment, history of cerebrovascular disease, gastrointestinal ulcer bleeding or requiring treatment, control bad diabetes, renal failure, active hepatitis and cirrhosis, liver failure, etc.) 4)has a fever, suspected infection 5)pleural effusion requiring treatment, pericardial effusion example 6)a clear interstitial pneumonia or pulmonary fibrosis in the chest X photos and chest CT 7)a history of drug hypersensitivity 8)a history of severe hypersensitivity for the components of the therapeutic agent (nab-paclitaxel) 9) a possibility of pregnancy and pregnancy, or breast-feeding 10)history of serious mental illness or are under treatment, patients judged that the participation in examination is difficult 11)HBs antigen-positive 12)Other cases of the physician has determined to be inappropriate as a target

发起方

SHINKO HOSPITA